NCT01594242
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Blood Protein Disorders
Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.
3,042 public trials
567 recruiting studies
Blood Protein Disorders trial results
NCT00711828
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +35 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01246063
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT02632786
- Conditions
- AL Amyloidosis, Alzheimer Disease, Amyloidosis, +22 more
- Locations
-
- City of Hope Duarte, California, United States
- Stanford Cancer Institute (SCI) Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Mayo Clinic Jacksonville, Florida, United States
NCT01383928
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- UCSF Medical Center Berkeley, California, United States
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Stanford, California, United States
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma
NCT01556438
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyoto, Japan
NCT00807599
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
- Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
- Memorial Sloan Kettering West Harrison Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02026505
- Conditions
- Blood Protein Disorders, Cardiotoxins, Cardiovascular Diseases, +16 more
- Locations
-
Not specified
NCT02497378
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hiroshima, Japan
- Hitachi, Japan
- Nagoya, Japan
- Shibuya City, Japan
NCT00115778
- Conditions
- Agammaglobulinemia, Blood Protein Disorders, Hematologic Diseases, +7 more
- Locations
-
- New York Presbyterian Hospital Lung Transplant Program New York, United States